Infection Probability Score: A predictor of Clostridium difficile-associated disease onset in patients with haematological malignancy

European Journal of Oncology Nursing

Volumn 15, Issue 5, 2011, Pages 404-409

  Apostolopoulou, Eleni ^a   Raftopoulos, Vasilios ^b   Terzis, Konstantinos ^c   Elefsiniotis, Ioannis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

^c Halkida General Hospital   (Greece)

Author keywords

APACHE II; Clostridium difficile associated disease; Healthcare associated infections; Hematology; Infection probability score; KARNOFSKY

Indexed keywords

ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; BLOOD DISEASE; CLOSTRIDIUM DIFFICILE; COMPARATIVE STUDY; CROSS INFECTION; FEMALE; GREECE; HEALTH SURVEY; HUMAN; INCIDENCE; KARNOFSKY PERFORMANCE STATUS; MALE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; PILOT STUDY; PREDICTIVE VALUE; PROBABILITY; PSEUDOMEMBRANOUS COLITIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APACHE; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; GREECE; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; PILOT PROJECTS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROBABILITY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 80055099352     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2010.11.002     Document Type: Article

References (49)

1. Anand A., Glatt A.E. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clinical Infectious Diseases 1993, 17:109-113.
2. Apostolopoulou E., Raftopoulos V., Terzis K., Elefsiniotis I. Infection Probability Score, APACHE II and KARNOFSKY scoring systems as predictors of bloodstream infection onset in hematology-oncology patients. BMC Infectious Diseases 2010, 26(10):135.
3. Barbut F., Petit J.C. Epidemiology of Clostridium difficile-associated infections. Clinical Microbiology and Infection 2001, 7:405-410.
4. Bartlett J.G. Antibiotic-associated diarrhea. Clinical Infectious Diseases 1992, 15:573-581.
5. Beaujean D.J., Blok H.E., Vandenbroucke-Grauls C.M., Weersink A.J., Raymakers J.A., Verhoef J. Surveillance of nosocomial infections in geriatric patients. Journal of Hospital Infection 1997, 36:275-284.
6. Berild D., Smaabrekke L., Halvorsen D.S., Lelek M., Stahlsberg E.M., Ringertz S.H. Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals. Journal of Hospital Infection 2003, 54:202-206.
7. Blot E., Escande M.C., Besson D., Barbut F., Granpeix C., Asselain B., Falcou M.C., Pouillart P. Outbreak of Clostridium difficile-related diarrhea in an adult oncology unit: risk factors and microbiological characteristics. Journal of Hospital Infection 2003, 53:187-192.
8. Brazier J.S., Duerden B.I. Guidelines for optimal surveillance of Clostridium difficile infection in Hospitals. Communicable Disease and Public Health 1998, 1:229-230.
9. Brown E., Talbot G.H., Axelrod P., Provencher M., Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhoea. Infection Control and Hospital Epidemiology 1990, 11:283-290.
10. Clabots C.R., Johnson S., Olson M.M., Peterson L.R., Gerding D.N. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. The Journal of Infectious Diseases 1992, 166:561-567.
11. Cohen S.H., Tang Y.J., Muenzer J., Gumerlock P.H., Silva J. Isolation of various genotypes of Clostridium difficile from patients and the environment in an oncology ward. Clinical Infectious Diseases 1997, 24:889-893.
12. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., Clifford McDonald L., Pepin J., Wilcox M.H. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 Update by the Society for healthcare epidemiology of America (SHEA) and the Infectious diseases Society of America (IDSA). Infection Control and Hospital Epidemiology 2010, 31(5):431-455.
13. Cooper G.S., Lederman M.M., Salata R.A. A predictive model to identify Clostridium difficile toxin in hospitalized patients with diarrhea. The American Journal of Gastroenterology 1996, 91:80-84.
14. Dallal R.M., Harbrecht B.G., Boujoukas A.J., Sirio C.A., Farkas L.M., Lee K.K., Simmons R.L. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Annals of Surgery 2002, 235:363-372.
15. Dettenkofer M., Ebner W., Bertz H., Babikir R., Finke J., Frank U., Rüden H., Daschner F.D. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem- cell transplantation. Bone Marrow Transplant 2003, 31:795-801.
16. Emoto M., Kawarabayashi T., Hachisuga M.D., Eguchi F., Shirakawa K. Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecologic Oncology 1996, 61:369-372.
17. Gifford A.H., Kirkland K.B. Risk factors for Clostridium difficille-associated diarrhea on an adult hematology-oncology ward. European Journal of Clinical Microbiology & Infectious Diseases 2006, 25:751-755.
18. Gorschlüter M., Glasmacher A., Hahn C., Schakowski F., Ziske C., Molitor E., Marklein G., Sauerbruch T., Schmidt-Wolf I.G. Clostridium difficile infection in patients with neutropenia. Clinical Infectious Diseases 2001, 33:786-791.
19. Högenauer C., Hammer H.F., Krejs G.J., Reisinger E.C. Mechanisms and management of antibiotic-associated diarrhea. Clinical Infectious Diseases 1998, 27:702-710.
20. Hornbuckle K., Chak A., Lazarus H.M., Cooper G.S., Kutteh L.A., Gucalp R., Carlisle P.S., Sparano J., Parker P., Salata R.A. Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients. Annals of Oncology 1998, 9:307-311.
21. Husain A., Aptaker L., Spriggs D.R., Barakat R.R. Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens. Gynecologic Oncology 1998, 71:104-107.
22. Johnson S., Samore M.H., Farrow K.A., Killgore G.E., Tenover F.C., Lyras D., Rood J.I., DeGirolami P., Baltch A.L., Rafferty M.E., Pear S.M., Gerding D.N. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. The New England Journal of Medicine 1999, 341:1645-1651.
23. Karnofsky D.A., Burchanot J.H. The Clinical Evaluation of Chemotherapeutic Agents 1949, New York Columbia Univ. Press, New York.
24. Kelly C.P., Pothoulakis C., LaMont J.T. Clostridium difficile colitis. The New England Journal of Medicine 1994, 330:257-262.
25. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Critical Care Medicine 1985, 13:818-829.
26. Kuijper E.J., Coignard B., Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clinical Microbiology and Infection 2006, 12:2-18. ESCMID Study Group for Clostridium difficile, EU Member StatesEU Member States, European Centre for Disease Prevention and ControlEuropean Centre for Disease Prevention and Control.
27. Kuijper E.J., Coignard B., Brazier J.S., Suetens C., Drudy D., Wiuff C., Pituch H., Reichert P., Schneider F., Widmer A.F., Olsen K.E., Allerberger F., Notermans D.W., Barbut F., Delmée M., Wilcox M., Pearson A., Patel B.C., Brown D.J., Frei R., Akerlund T., Poxton I.R., Tüll P. Update of Clostridium difficile-associated disease dye to PCR ribotype 027 in Europe. Euro Surveillance 2007, 12. EI-2.
28. Kyne L., Hamel M.B., Polavaram R., Kelly C.P. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clinical Infectious Diseases 2002, 34:346-353.
29. Larson H.E., Parry J.V., Price A.B., Davies D.R., Dolby J., Tyrrell D.A. Undescribed toxin in pseudomembranous colitis. British Medical Journal 1977, 1:1246-1248.
30. Martini A., Gottin L., Melot C., Vincent J.L. A prospective evaluation of the Infection Probability Score (IPS) in the intensive care unit. Journal of Infection 2008, 56:313-318.
31. McFarland L.V., Surawicz C.M., Stamm W.E. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. The Journal of Infectious Diseases 1990, 162:678-684.
32. McNulty C., Logan M., Donald I.P., Ennis D., Taylor D., Baldwin R.N., Bannerjee M., Cartwright K.A. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. Journal of Antimicrobial Chemotherapy 1997, 40:707-711.
33. Morris-Jg J., Jarvis W.R., Nunez-Montiel O.L., et al. Clostridium difficile: colonization and toxin production in a cohort of patients with malignant hematologic disorders. Archives of Internal Medicine 1984, 144:967-969.
34. Mylonakis E., Ryan E.T., Calderwood S.B. Clostridium difficile-Associated diarrhea: a review. Archives of Internal Medicine 2001, 161:525-533.
35. Palmore T.N., Sohn S., Malak S.F., Eagan J., Sepkowitz K.A. Risk factors for acquisition of Clostridium difficile-associated diarrrhea among outpatients at a cancer hospital. Infection Control and Hospital Epidemiology 2005, 26:680-684.
36. Pepin J., Alary M.E., Valiquette L., Raiche E., Ruel J., Fulop K., Godin D., Bourassa C. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clinical Infectious Diseases 2005, 40:1591-1597.
37. Peres Bota D., Mélot C., Lopes Ferreira F., Vincent J.L. Infection Probability Score (IPS): a method to help assess the probability of infection in critically ill patients. Critical Care Medicine 2003, 31:2579-2584.
38. Safavi M., Honarmand A. Comparison of infection probability score, APACHE II and APACHE III scoring systems in predicting need for ventilator and ventilation duration in critically ill patients. Archives of Iranian Medicine 2007, 10:354-360.
39. Schag C.C., Heinrich R.L., Ganz P.A. Karnofsky performance status revisited: reliability, validity and guidelines. Journal of Clinical Oncology 1984, 2:187-193.
40. Schalk E., Bohr U.R.M., König B., Scheinpflug K., Mohren M. Clostridium difficile associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia. Annals of Hematology 2010, 89:9-14.
41. Schwaber M.J., Simhon A., Block C., Roval V., Ferderber N., Shapiro M. Factors associated with nosocomial diarrhea and Clostridium diffcile-associated disease on the adult wards of an urban tertiary care hospital. European Journal of Clinical Microbiology & Infectious Diseases 2000, 19:9-15.
42. Sohn S., Climo M., Diekema D., Fraser V., Herwaldt L., Marino S., Noskin G., Perl T., Song X., Tokars J., Warren D., Wong E., Yokoe D.S., Zembower T., Sepkowitz K.A. Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals. Infection Control and Hospital Epidemiology 2005, 26:676-679. Prevention Epicenter Hospitals.
43. Svenungsson B., Burman L.G., Jalakas-Pörnull K., Lagergren A., Struwe J., Akerlund T. Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. Journal of Clinical Microbiology 2003, 41:4031-4037.
44. Szczesny A., Kański A., Martirosian G. Incidence of pseudomembranous colitis after vancomycin-treated MRSA infection. Clinical Microbiology and Infection 2002, 8:58-59.
45. Talon D., Bailly P., Delmée M., Thouverez M., Mulin B., Iehl-Robert M., Cailleaux V., Michel-Briand Y. Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14:987-993.
46. Tan E.T., Robertson C.A., Brynildsen S., Bresnitz E., Tan C., McDonald C. Clostridium difficile-associated disease in New Jersey hospitals, 2000-2004. Emerging Infectious Diseases 2007, 13:498-500.
47. Tillett W.S., Francis T. Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. The Journal of Experimental Medicine 1930, 52:561-571.
48. Vonberg R.P., Reichardt C., Behnke M., Schwab F., Zindler S., Gastmeier P. Costs of nosocomial Clostridium difficile-associated diarrhoea. Journal of Hospital Infection 2008, 70(1):15-20.
49. Wilcox M.H., Fawley W.N., Wigglesworth N., Parnell P., Verity P., Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. Journal of Hospital Infection 2003, 54:109-114.